Introduction
The immune response of patients with leprosy to antigens of Mycobacterium leprae correla tes with a spectrum based upon clinical and histopathologic categories (I) . Patients at the tu berculoid pole have strong cell-mediated immune responses whereas , patients at the lepromatous pole are selectively unresponsive to antigens of M. ieprae. The identification of epitopes recognized by lymphocytes from the resistant tuberculoid patients are important in designing an antileprosy vaccine. In addition, the mechanism of immune unresponsiveness of lepromatous patients is of fundamental importance in contributing to our understanding of immune toler�nce in man (2) .
The overwhelming majority of investigative studies into the immunology of leprosy has been performed on cells obtained from peripheral blood of patients. For example, Mehra et ai. described lepromin-induced suppressor T-lymphocytes in lepromatous patients which were thought to contribute to the unresponsiveness of these patients (3) (4) (5) . We have confirm ed these studies by measuring the effect of Dharmendra lepromin on the Concanavalin A (Con A) response of peripheral blood mononuclear cells (PBMC). We were able to de monstrate suppressor cell activity in lepromatous and borderline lepromatous patients, but not in tuberculoid patients, normals or contacts (6) .
Mehra further demonstrated that suppressor T-lymphocytes could be induced to suppress PBMC Con A responses by phenolic glycolipid-l (PG-I) (7) . In collaboration with Bloom and Brennan (8-10), we sought to define the epitope recognized by these suppressor cells.
Suppression in lepromatous patients was observed with both synthetic terminal disaccharide and monosaccharide conjugated to bovine serum albumin. Thus it appears that the terminal sugar unit of PG-l is the carbohydrate epitope recognized by T -suppressor cells from le promatous patients. "-In taking care of increasing numbers of patients at Los Angeles County Hospital, we re cognize that leprosy is a disease of skin and nerves. The focal point of the immune response to M. ieprae is the granuloma, a collection of lymphocytes and macrophages. Therefore , it is important to critically evaluate these cells in sites of disease activity.
Immunopathology of Leprosy
Phenotypic marker analysis of lymphocytes in skin lesions using monoclonal antibodies and immunoperoxidase techniques was performed. In tuberculoid leprosy lesions, T4 (helper/in-R L Modlin et at. ducer) lymphocytes were more numerous than T8 (suppressor/cytotoxic) lymphocytes. Inter estingly, suppressor lymphocytes were localized at the periphery of the granuloma. In le promatous lesions, suppressor lymphocytes were more numerous than helper lymphocytes. These differences were not observed in the peripheral blood., The peripheral blood helper: suppressor ratio in tuberculoid and lepromatous patients was identical, about ' 2: 1. Immuno peroxidase staining of tissues showed a 2: 1 ratio in tuberculoid lesions and a 1:2 ratio in le promatous lesions (11-14). American cutaneous leishmaniasis forms a spectrum similar to that of leprosy in that pa tients with localized disease have strong cell-mediated responses, while those with dis seminated disease are unresponsive. In collaboration with Jacinto Convit, we studied skin lesions of patients with leishmaniasis (15) . Patients with disseminated leishmaniasis have a suppressor cell excess in lesions similar to patients with lepromatous leprosy. However, we were surprised to find that patients with localized leishmaniasis, in direct contrast to those with tuberculoid leprosy, also had a suppressor/cytotoxic T8+ cell excess in lesions.
It was evident that T -lymphocyte phenotype alone was not sufficient to explain the im munopathogenesis of tissue lesions. Therefore , we sought to examine more specific markers of immune function (16) . Tac or interleukin-2 receptor bearing cells were present in similar numbers in all forms of leprosy and leishmaniasis. We t h en used a monoclonal antibody against IL-2 which identified large cells with cytoplasmic staining. These cells on double staining were found to be helper/inducer T -cells, not suppressor/cytotoxic T -cells and did not bear 11-2 receptors . . ' These cells were most probably IL-2 producing cells and could occa sionally be located near OKT6+ Langerhans cells which can present antigen( Quantitation of IL-2+ cells in skin lesions revealed a striking association with the strength of the cell-media ted response. There were ten times the numbers of IL-2 producing cells in 'tuberculoid le prosy as compared with lepromatous leprosy. Patients with localized leishmaniasis had grea ter numbers of IL-2 + cells in lesions than those with disseminated disease. Therefore , ex amination of molecules closely associated with immune fu nction is more specifically related to the immune response.
Langerhans' cells which are intraepidermal antigen-presenting cells, are more numerous in tuberculoid leprosy than lepromatous leprosy (1 1,17 ). In addition, we reported in 1983 that keratinocyte expression of Ia antigen was present in tuberculoid but not lepromatous leprosy (11). Nathan et al have demonstrated the relationship of keratinocyte la expression to interferon-gamma production (18) .
T -helper lymphocytes from tuberculoid lesions
Patient skin lesions seemed an ideal location to obtain immune cells reactive to M. /eprae for study: I) Cells in lesions would be easy to grow in culture because they are already activated (Tac +) in situ . 2) Cells in lesions should be concentrated for reactivity against M. leprae. 3) We decided to clone cells from lesions instead of peripheral blood because cell populations in the lesions were phenotypically different and therefore likely to be functionally differant than in the peripheral blood. 4) Finally, cloning cells from lesions would provide homogen ous populations of immune cells for fu nctional study.
Skin biopsy specimens were obtained from untreated patients with leprosy and extruded through a surgical steel mesh (19) . A single cell suspension was then labelled with mono clonal antibodies and analyzed and sorted with a FACS IV. T-cell lines were established or the lymphocytes were cloned by limiting dilution in the presence of interleukin-2 and irra diated PBMC , or for T4 cells in the presence of antigen as well. We are confident that with these methods, we obtained lymphocytes derived from skin lesions and not from blood ves sels within lesions. The helper to suppressor ratios were in agreement with those obtained by immunoperoxidase and in the case of lepromatous patients, diffe rent than the peripheral blood ratio.
T4 clones from tuberculoid lesions were assayed for proliferative responses to both le promin and PPO antigens. T-helper clones derived from tuberculoid lesions showed four pat terns of reactivity. Several clones were lepromin specific in that they responded strongly to lepromin, but only weakly to PPO. Several clones were reactive to epitopes shared by both M. leprae and M. tuberculosis. Some clones reacted more strongly to PPO , although weak Iy . A few clones were IL-2 dependent but did not proliferate in response to antigen.
Several of these T4 clones were studied more closely for species specificity against a panel of different species of mycobacteria. Again, M. /eprae specific clones were present in lesions. Clones were also identified which were crossreactive with most mycobacteria and those that were cross reactive with few mycobacteria. We have now assayed 62 clones from lesions of 3 tuberculoid patients. About half the clones are M. leprae specific, while half are cross reactive. It may be that both specific and cross reactive epitopes are important in the immune protection that these patients have.
To follow on the role of interferon-gamma in tuberculoid lesions, we assayed an M. le prae specific clone for interferon-gamma production by radioimmunoassay . This clone was able to proliferate and produce interferon-gamma in response to M. leprae but not M. tuber culosis. T4 lymphocytes from lepromatous lesions grown in an identical manner have so far proven to be unresponsive to M. /eprae antigens.
T -suppressor lymphocytes from lepromatous lesions
T8 lines or clones were assayed for lepromin-induced suppression of the peripheral blood Con A response. Normal PBMC were cocultured with the T8 line or clone in the presence or absence of lepromin and Con A. Percent suppression was caluculated as the diffe rence be tween triplicate cultures in the presence versus the absence of lepromin.
In 113 of the lines derived from lesions of 6 lepromatous patients, significant suppression was observed. In the remaining 2/3 of the lines from lepromatous lesions, no suppression was observed. In addition, in the 9 lines obtained from 6 tuberculoid patients lepromin-in duced suppression could not be demonstrated. In four of the lines tested that were triggered to suppress by lepromin, no suppression was induced by tetanus toxoid , an indication of anti gen specificity (19) .
Some lines appeared to suppress some donors but not others. To investigate whether a genetic restriction could explain this observation, 2 T8 suppressor clones were established from 2 lepromatous patients, HLA-OR type [4,-] and [4, 1] . These clones were assayed for lepromin-induced suppression of the con A response: of 6 normal donors , three shared the HLA-OR [4] type and three were mismatched (20) . When the first T8 clone was assayed with the class II MHC matched donors, suppression was observed . When this clone was assayed with the class II MHC mismatched donor, no suppression was observed. The second T8 clo ne also suppressed only when assayed with PBMC sharing class II antigens. There was no correlation with class I MHC. A T4 clone was used to control for the addition of cells and possible competition for IL-2 in the medium. No suppression was observed when this T4 clo ne was assayed with either matched or mismatched PBMC.
Because the biological significance of suppression of a mitogen response is unclear, we :-vished to ask the question: can these T8 clones suppress the antigen response of lepromin reactive T4 clones? To these T4 clones we added irradiated antigen presenting cells and le promin and then assayed for thymidine incorporation in the the presence or absence of the T8 or control nonreactive T4 clones. The T8+ clones were able to suppress the lepromin res ponse of the class II MHC matched but not mismatched T4 clone. Again, the T4 control clo- ne had no effect. A summary of the data demonstrating the MHC class II restriction is shown in Figure I . In conclusion, cloned suppressor T-cells derived from lepromatous leprosy skin lesions can be triggered by lepromin to suppress the con A response of norma! PBMC. These_ sup pressor T-cell clones can suppress the proliferative response of helper T-cell clones to le promin. This suppression is probably restricted by class II MHC antigens. Therefore , the un responsiveness of lepromatous leprosy patients to antigens of M. leprae may be related to the presence of these suppressor T-cells within lesions, perhaps by inhibiting ' Il-2 production. These methods provide a new means to study the immune response of patients to infec tion, neoplasia and autoimmune disease at the tissue level. In addition, the helper and sup pressor clones from leprosy skin lesions can be used to elucidate the range of cloned antigens and epitopes recognized by the T-Iymphocyte repertoire in leprosy.
